Literature DB >> 9160169

The electronic medication event monitor. Lessons for pharmacotherapy.

J Urquhart1.   

Abstract

Mesh：

Year:  1997        PMID： 9160169     DOI： 10.2165/00003088-199732050-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  51 in total

1.  Compliance with topical timolol treatment.

Authors:  M A Kass; M Gordon; R E Morley; D W Meltzer; J J Goldberg
Journal:  Am J Ophthalmol       Date:  1987-02-15       Impact factor: 5.258

2.  Compliance with anti-tuberculous therapy: a field trial of a pill-box with a concealed electronic recording device.

Authors:  R Cheung; J Dickins; P W Nicholson; A S Thomas; H H Smith; H E Larson; A A Deshmukh; R J Dobbs; S M Dobbs
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 3.  Intention-to-treat analysis and the goals of clinical trials.

Authors:  L B Sheiner; D B Rubin
Journal:  Clin Pharmacol Ther       Date:  1995-01       Impact factor: 6.875

4.  Prediction of diltiazem plasma concentration curves from limited measurements using compliance data.

Authors:  A Rubio; C Cox; M Weintraub
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

5.  Compliance in clinical trials of two nonbronchodilator, antiasthma medications.

Authors:  H Mawhinney; S L Spector; R A Kinsman; S C Siegel; G S Rachelefsky; R M Katz; A S Rohr
Journal:  Ann Allergy       Date:  1991-04

6.  Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected women.

Authors:  S M Geletko; M Segarra; K H Mayer; T C Fiore; F A Bettencourt; T P Flanigan; M N Dudley
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

7.  Improved compliance measures: applications in an ambulatory hypertensive drug trial.

Authors:  P Rudd; S Ahmed; V Zachary; C Barton; D Bonduelle
Journal:  Clin Pharmacol Ther       Date:  1990-12       Impact factor: 6.875

8.  A nebulizer chronolog to monitor compliance with inhaler use.

Authors:  D P Tashkin; C Rand; M Nides; M Simmons; R Wise; A H Coulson; V Li; H Gong
Journal:  Am J Med       Date:  1991-10-21       Impact factor: 4.965

9.  Compliance monitoring of NSAID drug therapy in ankylosing spondylitis, experiences with an electronic monitoring device.

Authors:  E de Klerk; S J van der Linden
Journal:  Br J Rheumatol       Date:  1996-01

10.  A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure.

Authors:  M W Rich; V Beckham; C Wittenberg; C L Leven; K E Freedland; R M Carney
Journal:  N Engl J Med       Date:  1995-11-02       Impact factor: 91.245
View more
  46 in total

Review 1.  Accounting for noncompliance in pharmacoeconomic evaluations.

Authors:  D A Hughes; A Bagust; A Haycox; T Walley
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 2.  Adverse events, compliance, and changes in therapy.

Authors:  R Düsing
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

3.  Pharmacokinetics, food intake requirements and tolerability of once-daily combinations of nelfinavir and low-dose ritonavir in healthy volunteers.

Authors:  R E Aarnoutse; J A H Droste; J J G van Oosterhout; P P Koopmans; M Popescu; P Reiss; Y A Hekster; D M Burger
Journal:  Br J Clin Pharmacol       Date:  2003-02       Impact factor: 4.335

4.  The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response.

Authors:  John Urquhart
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

Review 5.  Modeling and simulation of adherence: approaches and applications in therapeutics.

Authors:  Leslie A Kenna; Line Labbé; Jeffrey S Barrett; Marc Pfister
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

6.  Compliance-guided therapy : a new insight into the potential role of clinical pharmacologists.

Authors:  Alexia Blesius; Sylvie Chabaud; Michel Cucherat; Patrick Mismetti; Jean-Pierre Boissel; Patrice Nony
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 7.  Integrated pharmacokinetics and pharmacodynamics in drug development.

Authors:  Jasper Dingemanse; Silke Appel-Dingemanse
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

8.  Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children's Oncology Group study.

Authors:  Wendy Landier; Yanjun Chen; Lindsey Hageman; Heeyoung Kim; Bruce C Bostrom; Jacqueline N Casillas; David S Dickens; William E Evans; Kelly W Maloney; Leo Mascarenhas; A Kim Ritchey; Amanda M Termuhlen; William L Carroll; Mary V Relling; F Lennie Wong; Smita Bhatia
Journal:  Blood       Date:  2017-02-02       Impact factor: 22.113

9.  Pharmacokinetically based estimation of patient compliance with oral anticancer chemotherapies: in silico evaluation.

Authors:  Emilie Hénin; Michel Tod; Véronique Trillet-Lenoir; Catherine Rioufol; Brigitte Tranchand; Pascal Girard
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 10.  Cardiovascular medication: improving adherence using prompting mechanisms.

Authors:  Liam Glynn; Tom Fahey
Journal:  BMJ Clin Evid       Date:  2015-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.